Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * pregnant * 18 and over * monofetal pregnancy between 22+0 and 41+0 weeks of gestation * presenting a positive covid-19 rt-pcr test result after nasopharyngeal swab for one or more minor symptoms: cough, body temperature \>37,3 °c, shortness of breath, diarrhea, asthenia, anosmia, taste loss, myalgia * presenting no contraindication to hydroxychloroquine and azithromycin * informed consent signature * affiliated to social security scheme

inclusion criteria: * pregnant * 18 and over * monofetal pregnancy between 22+0 and 41+0 weeks of gestation * presenting a positive covid-19 rt-pcr test result after nasopharyngeal swab for one or more minor symptoms: cough, body temperature \>37,3 °c, shortness of breath, diarrhea, asthenia, anosmia, taste loss, myalgia * presenting no contraindication to hydroxychloroquine and azithromycin * informed consent signature * affiliated to social security scheme

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: - pregnant - 18 and over - monofetal pregnancy between 22+0 and 41+0 weeks of gestation - presenting a positive covid-19 rt-pcr test result after nasopharyngeal swab for one or more minor symptoms: cough, body temperature >37,3 °c, shortness of breath, diarrhea, asthenia, anosmia, taste loss, myalgia - presenting no contraindication to hydroxychloroquine and azithromycin - informed consent signature - affiliated to social security scheme

inclusion criteria: - pregnant - 18 and over - monofetal pregnancy between 22+0 and 41+0 weeks of gestation - presenting a positive covid-19 rt-pcr test result after nasopharyngeal swab for one or more minor symptoms: cough, body temperature >37,3 °c, shortness of breath, diarrhea, asthenia, anosmia, taste loss, myalgia - presenting no contraindication to hydroxychloroquine and azithromycin - informed consent signature - affiliated to social security scheme